Ceapro Inc. (CVE:CZO – Get Free Report) shares dropped 11.8% on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The firm’s 50-day moving average price is C$0.22 and its two-hundred day moving average price is C$0.23. The stock has a market cap of C$17.62 million, a PE ratio of -3.75 and a beta of 1.38. The company has a current ratio of 8.54, a quick ratio of 18.88 and a debt-to-equity ratio of 8.07.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Further Reading
- Five stocks we like better than Ceapro
- Top Stocks Investing in 5G Technology
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What to Know About Investing in Penny Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Differences Between Momentum Investing and Long Term Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
